ATE227738T1 - Peptide und dessen verwendungen gegen psoriasis - Google Patents
Peptide und dessen verwendungen gegen psoriasisInfo
- Publication number
- ATE227738T1 ATE227738T1 AT95909258T AT95909258T ATE227738T1 AT E227738 T1 ATE227738 T1 AT E227738T1 AT 95909258 T AT95909258 T AT 95909258T AT 95909258 T AT95909258 T AT 95909258T AT E227738 T1 ATE227738 T1 AT E227738T1
- Authority
- AT
- Austria
- Prior art keywords
- psoriasis
- peptide
- fragment
- methods
- peptides
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 108091008874 T cell receptors Proteins 0.000 abstract 3
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 101500027988 Mus musculus ADGRV1 subunit beta Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/182,967 US6413516B1 (en) | 1989-03-21 | 1994-01-14 | Peptides and methods against psoriasis |
| PCT/US1995/000658 WO1995019375A1 (en) | 1994-01-14 | 1995-01-13 | Peptides and methods against psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227738T1 true ATE227738T1 (de) | 2002-11-15 |
Family
ID=22670842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95909258T ATE227738T1 (de) | 1994-01-14 | 1995-01-13 | Peptide und dessen verwendungen gegen psoriasis |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6413516B1 (de) |
| EP (1) | EP0738281B1 (de) |
| JP (2) | JPH09508112A (de) |
| CN (1) | CN1138865A (de) |
| AT (1) | ATE227738T1 (de) |
| BR (1) | BR9506511A (de) |
| CA (1) | CA2179280A1 (de) |
| DE (1) | DE69528817T2 (de) |
| ES (1) | ES2184791T3 (de) |
| FI (1) | FI962836A (de) |
| MX (1) | MX9602473A (de) |
| NO (1) | NO962943L (de) |
| NZ (1) | NZ279987A (de) |
| WO (1) | WO1995019375A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
| GB0716992D0 (en) | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
| JP2009266963A (ja) * | 2008-04-23 | 2009-11-12 | Sumitomo Electric Ind Ltd | 窒化物系発光素子、及び半導体発光素子を製造する方法 |
| EP4211170A1 (de) * | 2020-09-11 | 2023-07-19 | Janssen Biotech, Inc. | Verfahren und zusammensetzungen zur modulation von beta-ketten-vermittelter immunität |
| US20240123022A1 (en) | 2021-12-16 | 2024-04-18 | Ramakrishna Reddy ISANAKA | A stable anti-angiogenic and anti-inflammatory pharmaceutical formulation and pharmaceutical combination for treatment and prevention of psoriasis |
| CN116466095B (zh) * | 2023-06-15 | 2023-09-01 | 朗肽生物制药股份有限公司 | 一种多肽及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG70553A1 (en) * | 1984-03-01 | 2000-02-22 | Univ Leland Stanford Junior | T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| US4886743A (en) * | 1985-04-24 | 1989-12-12 | California Institute Of Technology | Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
| NZ234586A (en) * | 1989-07-19 | 1993-02-25 | Arthur Allen Vandenbark | Peptide of a t-cell receptor capable of inducing protection from immune-related disease |
| CA2072356A1 (en) * | 1989-12-29 | 1991-06-30 | James L. Urban | Diagnosis and treatment of diseases |
| JPH06511241A (ja) | 1991-09-23 | 1994-12-15 | ジェネンテク，インコーポレイテッド | 自己免疫疾患の診断および治療 |
| JPH07506563A (ja) * | 1991-12-24 | 1995-07-20 | ザ イミューン レスポンス コーポレイション | 特異的ｔ細胞群による病原応答に起因する疾患に対してのワクチン接種および方法 |
-
1994
- 1994-01-14 US US08/182,967 patent/US6413516B1/en not_active Expired - Fee Related
-
1995
- 1995-01-13 WO PCT/US1995/000658 patent/WO1995019375A1/en active IP Right Grant
- 1995-01-13 NZ NZ279987A patent/NZ279987A/en unknown
- 1995-01-13 CN CN95191213A patent/CN1138865A/zh active Pending
- 1995-01-13 CA CA002179280A patent/CA2179280A1/en not_active Abandoned
- 1995-01-13 EP EP95909258A patent/EP0738281B1/de not_active Expired - Lifetime
- 1995-01-13 DE DE69528817T patent/DE69528817T2/de not_active Expired - Fee Related
- 1995-01-13 ES ES95909258T patent/ES2184791T3/es not_active Expired - Lifetime
- 1995-01-13 JP JP7519192A patent/JPH09508112A/ja not_active Withdrawn
- 1995-01-13 MX MX9602473A patent/MX9602473A/es not_active Application Discontinuation
- 1995-01-13 AT AT95909258T patent/ATE227738T1/de not_active IP Right Cessation
- 1995-01-13 BR BR9506511A patent/BR9506511A/pt not_active Application Discontinuation
-
1996
- 1996-07-12 FI FI962836A patent/FI962836A/fi unknown
- 1996-07-12 NO NO962943A patent/NO962943L/no not_active Application Discontinuation
-
2001
- 2001-02-28 JP JP2001055930A patent/JP2001288108A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US6413516B1 (en) | 2002-07-02 |
| AU1728295A (en) | 1995-08-01 |
| CA2179280A1 (en) | 1995-07-20 |
| DE69528817T2 (de) | 2003-09-11 |
| MX9602473A (es) | 1997-05-31 |
| BR9506511A (pt) | 1997-09-09 |
| JP2001288108A (ja) | 2001-10-16 |
| FI962836A0 (fi) | 1996-07-12 |
| NO962943L (no) | 1996-09-13 |
| EP0738281B1 (de) | 2002-11-13 |
| NZ279987A (en) | 1999-09-29 |
| FI962836A (fi) | 1996-07-12 |
| ES2184791T3 (es) | 2003-04-16 |
| JPH09508112A (ja) | 1997-08-19 |
| NO962943D0 (no) | 1996-07-12 |
| WO1995019375A1 (en) | 1995-07-20 |
| CN1138865A (zh) | 1996-12-25 |
| EP0738281A1 (de) | 1996-10-23 |
| AU697910B2 (en) | 1998-10-22 |
| DE69528817D1 (de) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972390A0 (fi) | Sytokiini nimeltä Lerk-7 | |
| BR0207775A (pt) | Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização | |
| ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
| KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
| NO20074516L (no) | Pattedyrcytokinlignende polypeptid-1 | |
| WO1999000410A3 (en) | Human extracellular matrix proteins | |
| HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
| DK0669979T3 (da) | C-C CKR-1, kemokinreceptor | |
| ES2150949T3 (es) | Regulacion de la actividad de linfocitos con la ayuda de peptidos hla. | |
| ATE442439T1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| ATE421531T1 (de) | Apoptose-bezogene verbindungen und deren verwendung | |
| ATE227738T1 (de) | Peptide und dessen verwendungen gegen psoriasis | |
| ATE303439T1 (de) | Intrazelluläre isoform von interleukin-1 rezeptor antagonist | |
| NO952385L (no) | Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen | |
| DE69533796D1 (de) | Für die glutamatabhängigen chloridkanäle kodierende dna | |
| NO963366L (no) | Peptider og fremgangsmåte for behandling av diabetes | |
| CY1108126T1 (el) | Μεθοδοι ελεγχου διαφοροποιησης και αναπτυξης κυτταρου χρησιμοποιωντας πρωτεϊνη συντηξης και ενα φαρμακο | |
| WO1999021994A3 (en) | Human vesicle membrane protein-like proteins | |
| ATE207757T1 (de) | Für die immun- und cns-therapie nutzbare, neuartige tripeptide | |
| EP0763597A3 (de) | Verwendung von Cytohesin-PH-Peptiden zur Beeinflussung der Adhäsionsfähigkeit von Integrinen | |
| DK0946591T3 (da) | Klonede glucagon-lignende peptid-2 receptorer | |
| ATE229983T1 (de) | Maspin- ein neues serpin mit tumor unterdrückender aktivität | |
| DE69631624D1 (de) | Antikörper gegen menschliches restrictin | |
| WO1998041538A3 (en) | Novel human cytokine/steroid receptor protein | |
| CA2228572A1 (en) | Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |